Kopran Limited — Updates, 28-04-2025: Press Release

Kopran Research Laboratories Limited, a wholly owned subsidiary of Kopran Ltd., has successfully concluded a recent USFDA surveillance inspection at its API unit in Mahad, Maharashtra. The inspection, conducted from April 21 to April 25, 2025, concluded without any observations, suggesting a clean report, which typically reflects positively on the facility's operational standards and compliance. This outcome can bolster Kopran's reputation in international markets and may enhance investor confidence. With compliance maintained at its API unit, the company is well-positioned for potential growth opportunities in export markets. Investors should monitor the ongoing developments as the company seeks to capitalize on this positive result.